Favourable outcome of coronavirus disease 2019 in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer receiving alectinib
Since February 21, 2020, when the first Italian patient was admitted to the hospital due to severe coronavirus disease 2019 (COVID-19) and found positive to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), this infection has spread through Italy, quickly becoming the largest COVID-19 outbreak outside Asia [1]. On March 12th, the World Health Organisation (WHO) declared COVID-19 a pandemic, placing the WHO European Region at the centre of the pandemic. Elderly people and those with pre-existing health conditions are most at risk of life-threatening complications [2].
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Michele Montrone, Annamaria Catino, Vincenzo O. Palmieri, Vito Longo, Domenico Galetta Tags: Letter to the Editor Source Type: research
More News: Cancer | Cancer & Oncology | Coronavirus | COVID-19 | Hospitals | Italy Health | Lung Cancer | Lymphoma | Non-Small Cell Lung Cancer | Outbreaks | Pandemics | Respiratory Medicine | SARS | WHO